<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <title>MyDailyApple News Alert: Top Stories</title>
  <link href="http://www.mydailyapple.com/news_alert/topfeed/daily" rel="self"/>
  <link href="http://www.mydailyapple.com/news" rel="alternate"/>
  <id>http://www.mydailyapple.com/news_alert/topfeed/daily</id>
  <updated>2010-03-10T00:04:07Z</updated>
  <entry>
    <title type="html">How to... survive a heart attack</title>
    <id>tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fwww.dailymail.co.uk%2Fhealth%2Findex.rss%3Aarticle-1256526%2FHow--survive-heart-attack.html%3FITO%3D1490</id>
    <link href="http://www.mydailyapple.com/follow?doc=s3%3Ahttp%253A%2F%2Fwww.dailymail.co.uk%2Fhealth%2Findex.rss%3Aarticle-1256526%2FHow--survive-heart-attack.html%3FITO%3D1490" rel="alternate"/>
    <updated>2010-03-10T00:04:07Z</updated>
    <author>
      <name>http://www.dailymail.co.uk/health/index.rss</name>
    </author>
    <summary type="html">&lt;p&gt;&lt;img
src="http://i.dailymail.co.uk/i/pix/2010/03/09/article-1256526-0623A5720000044D-954_87x84.jpg"
 width="87" height="84" /&gt;
&lt;br /&gt;
The fact is that the earlier you get treatment, the better your
chances. So please do make a fuss and ring 999.&lt;/p&gt;</summary>
    <content type="html">&lt;p&gt;&lt;img
src="http://i.dailymail.co.uk/i/pix/2010/03/09/article-1256526-0623A5720000044D-954_87x84.jpg"
 width="87" height="84" /&gt;
&lt;br /&gt;
The fact is that the earlier you get treatment, the better your
chances. So please do make a fuss and ring 999.&lt;/p&gt;</content>
  </entry>
  <entry>
    <title type="html">Life Technologies, TGen And US Oncology Partner On Groundbreaking Breast Cancer Sequencing Research</title>
    <id>tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fwww.medicalnewstoday.com%2Frss%2Fbreastcancer.xml%3Ahttp%3A%2F%2Fmnt.to%2Ff%2F3yD5</id>
    <link href="http://www.mydailyapple.com/follow?doc=s3%3Ahttp%253A%2F%2Fwww.medicalnewstoday.com%2Frss%2Fbreastcancer.xml%3Ahttp%3A%2F%2Fmnt.to%2Ff%2F3yD5" rel="alternate"/>
    <updated>2010-03-10T00:04:07Z</updated>
    <author>
      <name>http://www.medicalnewstoday.com/rss/breastcancer.xml</name>
    </author>
    <summary type="html">&lt;p&gt;Life Technologies Corporation (NASDAQ:LIFE) announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies...&lt;/p&gt;</summary>
    <content type="html">&lt;p&gt;Life Technologies Corporation (NASDAQ:LIFE) announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies...&lt;/p&gt;</content>
  </entry>
  <entry>
    <title type="html">Painkillers may increase risk of hearing loss</title>
    <id>tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Ffeeds.chicagotribune.com%2Fchicagotribune%2Fhealth%2F%3Ahttp%3A%2F%2Fwww.chicagotribune.com%2Fhealth%2Fla-he-0308-capsule-20100308%2C0%2C6772927.story%3Ftrack%3Drss</id>
    <link href="http://www.mydailyapple.com/follow?doc=s3%3Ahttp%253A%2F%2Ffeeds.chicagotribune.com%2Fchicagotribune%2Fhealth%2F%3Ahttp%3A%2F%2Fwww.chicagotribune.com%2Fhealth%2Fla-he-0308-capsule-20100308%2C0%2C6772927.story%3Ftrack%3Drss" rel="alternate"/>
    <updated>2010-03-10T00:04:07Z</updated>
    <author>
      <name>http://feeds.chicagotribune.com/chicagotribune/health/</name>
    </author>
    <summary type="html">&lt;p&gt;In a study, men who regularly use analgesics reported hearing loss.

&lt;br /&gt;
&lt;br /&gt;
 Perhaps it wasn't those years of listening to rock 'n' roll that
damaged my hearing after all; regular use of aspirin, acetaminophen
and other analgesics appears to substantially increase the risk of
hearing loss, especially in men younger than 50.&lt;/p&gt;</summary>
    <content type="html">&lt;p&gt;In a study, men who regularly use analgesics reported hearing loss.

&lt;br /&gt;
&lt;br /&gt;
 Perhaps it wasn't those years of listening to rock 'n' roll that
damaged my hearing after all; regular use of aspirin, acetaminophen
and other analgesics appears to substantially increase the risk of
hearing loss, especially in men younger than 50.&lt;/p&gt;</content>
  </entry>
  <entry>
    <title type="html">Researchers: AIDS virus can hide in bone marrow</title>
    <id>tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fseattletimes.nwsource.com%2Frss%2Fhealth.xml%3A%2Fhtml%2Fnationworld%2F2011284818_aids08.html%3Fsyndication%3Drss</id>
    <link href="http://www.mydailyapple.com/follow?doc=s3%3Ahttp%253A%2F%2Fseattletimes.nwsource.com%2Frss%2Fhealth.xml%3A%2Fhtml%2Fnationworld%2F2011284818_aids08.html%3Fsyndication%3Drss" rel="alternate"/>
    <updated>2010-03-10T00:04:07Z</updated>
    <author>
      <name>http://seattletimes.nwsource.com/rss/health.xml</name>
    </author>
    <summary type="html">&lt;p&gt;The virus that causes AIDS can hide in the bone marrow, avoiding drugs and later awakening to cause illness, according to new research that could point the way toward better treatments for the disease.&lt;/p&gt;</summary>
    <content type="html">&lt;p&gt;The virus that causes AIDS can hide in the bone marrow, avoiding drugs and later awakening to cause illness, according to new research that could point the way toward better treatments for the disease.&lt;/p&gt;</content>
  </entry>
  <entry>
    <title type="html">Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure [Heart Failure]</title>
    <id>tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fcirc.ahajournals.org%3Ahttp%3A%2F%2Fcirc.ahajournals.org%2Fcgi%2Fcontent%2Fshort%2F121%2F9%2F1086%3Frss%3D1</id>
    <link href="http://www.mydailyapple.com/follow?doc=s3%3Ahttp%253A%2F%2Fcirc.ahajournals.org%3Ahttp%3A%2F%2Fcirc.ahajournals.org%2Fcgi%2Fcontent%2Fshort%2F121%2F9%2F1086%3Frss%3D1" rel="alternate"/>
    <updated>2010-03-09T00:24:47Z</updated>
    <author>
      <name>http://circ.ahajournals.org</name>
    </author>
    <summary type="html">&lt;p&gt;&lt;p&gt;
&lt;b&gt;
  &lt;i&gt;Background&amp;#8212;&lt;/i&gt;
&lt;/b&gt; Previous studies suggest that management of ambulatory
hemodynamics may improve outcomes in chronic heart failure. We
conducted a prospective, observational, first-in-human study of a
physician-directed patient self-management system targeting left
atrial pressure.&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;
  &lt;i&gt;Methods and Results&amp;#8212;&lt;/i&gt;
&lt;/b&gt; Forty patients with reduced or preserved left ventricular
ejection fraction and a history of New York Heart Association class
III or IV heart failure and acute decompensation were implanted
with an investigational left atrial pressure monitor, and readings
were acquired twice daily. For the first 3 months, patients and
clinicians were blinded as to these readings, and treatment
continued per usual clinical assessment. Thereafter, left atrial
pressure and individualized therapy instructions guided by these
pressures were disclosed to the patient. Event-free survival was
determined over a median follow-up of 25 months (range 3 to 38
months). Survival without decompensation was 61% at 3 years, and
events tended to be less frequent after the first 3 months (hazard
ratio 0.16 [95% confidence interval 0.04 to 0.68], 
&lt;i&gt;P&lt;/i&gt;=0.012). Mean daily left atrial pressure fell from 17.6 mm
Hg (95% confidence interval 15.8 to 19.4 mm Hg) in the first 3
months to 14.8 mm Hg (95% confidence interval 13.0 to 16.6 mm Hg; 
&lt;i&gt;P&lt;/i&gt;=0.003) during pressure-guided therapy. The frequency of
elevated readings (&amp;gt;25 mm Hg) was reduced by 67% (
&lt;i&gt;P&lt;/i&gt;&amp;lt;0.001). There were improvements in New York Heart
Association class (&amp;#8211;0.7&#177;0.8, 
&lt;i&gt;P&lt;/i&gt;&amp;lt;0.001) and left ventricular ejection fraction (7&#177;10%, 
&lt;i&gt;P&lt;/i&gt;&amp;lt;0.001). Doses of angiotensin-converting
enzyme/angiotensin-receptor blockers and &amp;#946;-blockers were
uptitrated by 37% (
&lt;i&gt;P&lt;/i&gt;&amp;lt;0.001) and 40% (
&lt;i&gt;P&lt;/i&gt;&amp;lt;0.001), respectively, whereas doses of loop diuretics
fell by 27% (
&lt;i&gt;P&lt;/i&gt;=0.15).&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;
  &lt;i&gt;Conclusions&amp;#8212;&lt;/i&gt;
&lt;/b&gt; Physician-directed patient self-management of left atrial
pressure has the potential to improve hemodynamics, symptoms, and
outcomes in advanced heart failure.&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;
  &lt;i&gt;Clinical Trial Registration Information&amp;#8212;&lt;/i&gt;
&lt;/b&gt; URL: http://www.clinicaltrials.gov. Unique identifier:
NCT00547729.&lt;/p&gt;&lt;/p&gt;</summary>
    <content type="html">&lt;p&gt;&lt;p&gt;
&lt;b&gt;
  &lt;i&gt;Background&amp;#8212;&lt;/i&gt;
&lt;/b&gt; Previous studies suggest that management of ambulatory
hemodynamics may improve outcomes in chronic heart failure. We
conducted a prospective, observational, first-in-human study of a
physician-directed patient self-management system targeting left
atrial pressure.&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;
  &lt;i&gt;Methods and Results&amp;#8212;&lt;/i&gt;
&lt;/b&gt; Forty patients with reduced or preserved left ventricular
ejection fraction and a history of New York Heart Association class
III or IV heart failure and acute decompensation were implanted
with an investigational left atrial pressure monitor, and readings
were acquired twice daily. For the first 3 months, patients and
clinicians were blinded as to these readings, and treatment
continued per usual clinical assessment. Thereafter, left atrial
pressure and individualized therapy instructions guided by these
pressures were disclosed to the patient. Event-free survival was
determined over a median follow-up of 25 months (range 3 to 38
months). Survival without decompensation was 61% at 3 years, and
events tended to be less frequent after the first 3 months (hazard
ratio 0.16 [95% confidence interval 0.04 to 0.68], 
&lt;i&gt;P&lt;/i&gt;=0.012). Mean daily left atrial pressure fell from 17.6 mm
Hg (95% confidence interval 15.8 to 19.4 mm Hg) in the first 3
months to 14.8 mm Hg (95% confidence interval 13.0 to 16.6 mm Hg; 
&lt;i&gt;P&lt;/i&gt;=0.003) during pressure-guided therapy. The frequency of
elevated readings (&amp;gt;25 mm Hg) was reduced by 67% (
&lt;i&gt;P&lt;/i&gt;&amp;lt;0.001). There were improvements in New York Heart
Association class (&amp;#8211;0.7&#177;0.8, 
&lt;i&gt;P&lt;/i&gt;&amp;lt;0.001) and left ventricular ejection fraction (7&#177;10%, 
&lt;i&gt;P&lt;/i&gt;&amp;lt;0.001). Doses of angiotensin-converting
enzyme/angiotensin-receptor blockers and &amp;#946;-blockers were
uptitrated by 37% (
&lt;i&gt;P&lt;/i&gt;&amp;lt;0.001) and 40% (
&lt;i&gt;P&lt;/i&gt;&amp;lt;0.001), respectively, whereas doses of loop diuretics
fell by 27% (
&lt;i&gt;P&lt;/i&gt;=0.15).&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;
  &lt;i&gt;Conclusions&amp;#8212;&lt;/i&gt;
&lt;/b&gt; Physician-directed patient self-management of left atrial
pressure has the potential to improve hemodynamics, symptoms, and
outcomes in advanced heart failure.&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;
  &lt;i&gt;Clinical Trial Registration Information&amp;#8212;&lt;/i&gt;
&lt;/b&gt; URL: http://www.clinicaltrials.gov. Unique identifier:
NCT00547729.&lt;/p&gt;&lt;/p&gt;</content>
  </entry>
  <entry>
    <title type="html">Differences in Patient Survival After Acute Myocardial Infarction by Hospital Capability of Performing Percutaneous Coronary Intervention: Implications for Regionalization [Original Investigation]</title>
    <id>tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Farchinte.ama-assn.org%3Ahttp%3A%2F%2Farchinte.ama-assn.org%2Fcgi%2Fcontent%2Fshort%2F170%2F5%2F433%3Frss%3D1</id>
    <link href="http://www.mydailyapple.com/follow?doc=s3%3Ahttp%253A%2F%2Farchinte.ama-assn.org%3Ahttp%3A%2F%2Farchinte.ama-assn.org%2Fcgi%2Fcontent%2Fshort%2F170%2F5%2F433%3Frss%3D1" rel="alternate"/>
    <updated>2010-03-09T00:24:47Z</updated>
    <author>
      <name>http://archinte.ama-assn.org</name>
    </author>
    <summary type="html">&lt;p&gt;&lt;p&gt;
&lt;b&gt;Background&amp;#160;&lt;/b&gt; There are increasing calls for
regionalization of acute myocardial infarction (AMI) care in the
United States to hospitals with the capacity to perform
percutaneous coronary intervention (PCI). Whether regionalization
will improve outcomes depends in part on the magnitude of existing
differences in outcomes between PCI and non-PCI hospitals within
the same health care region.&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;Methods&amp;#160;&lt;/b&gt; A 100% sample of claims from Medicare
fee-for-service beneficiaries 65 years or older hospitalized for
AMI between January 1, 2004, and December 31, 2006, was used to
calculate hospital-level, 30-day risk-standardized mortality rates
(RSMRs). The RSMRs between PCI and local non-PCI hospitals were
compared within local health care regions defined by hospital
referral regions (HRRs).&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;Results&amp;#160;&lt;/b&gt; A total of 523&amp;#160;119 AMI patients was
admitted to 1382 PCI hospitals, and 194&amp;#160;909 AMI patients were
admitted to 2491 non-PCI hospitals in 295 HRRs with at least 1 PCI
and 1 non-PCI hospital. Although PCI hospitals had lower RSMRs than
non-PCI hospitals (mean, 16.1% vs 16.9%; 
&lt;i&gt;P&lt;/i&gt;&amp;#160;&amp;lt;&amp;#160;.001), considerable overlap was seen in
RSMRs between non-PCI and PCI hospitals within the same HRR. In 80
HRRs, the RSMRs at the best-performing PCI hospital were lower than
those at local non-PCI hospitals by 3% or more. Among the remaining
HRRs, the RSMRs at the best-performing PCI hospital were lower by
1.5% to 3.0% in 104 HRRs and by greater than 0 to 1.5% in 74 HRRs.
In 37 HRRs, the RSMRs at the best-performing PCI hospital were no
better or were higher than at local non-PCI hospitals.&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;Conclusions&amp;#160;&lt;/b&gt; The magnitude of benefit from
comprehensively regionalizing AMI care to PCI hospitals appears to
vary greatly across HRRs. These findings support a tailored
regionalization policy that targets areas with the greatest outcome
differences between PCI and local non-PCI hospitals.&lt;/p&gt;&lt;/p&gt;</summary>
    <content type="html">&lt;p&gt;&lt;p&gt;
&lt;b&gt;Background&amp;#160;&lt;/b&gt; There are increasing calls for
regionalization of acute myocardial infarction (AMI) care in the
United States to hospitals with the capacity to perform
percutaneous coronary intervention (PCI). Whether regionalization
will improve outcomes depends in part on the magnitude of existing
differences in outcomes between PCI and non-PCI hospitals within
the same health care region.&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;Methods&amp;#160;&lt;/b&gt; A 100% sample of claims from Medicare
fee-for-service beneficiaries 65 years or older hospitalized for
AMI between January 1, 2004, and December 31, 2006, was used to
calculate hospital-level, 30-day risk-standardized mortality rates
(RSMRs). The RSMRs between PCI and local non-PCI hospitals were
compared within local health care regions defined by hospital
referral regions (HRRs).&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;Results&amp;#160;&lt;/b&gt; A total of 523&amp;#160;119 AMI patients was
admitted to 1382 PCI hospitals, and 194&amp;#160;909 AMI patients were
admitted to 2491 non-PCI hospitals in 295 HRRs with at least 1 PCI
and 1 non-PCI hospital. Although PCI hospitals had lower RSMRs than
non-PCI hospitals (mean, 16.1% vs 16.9%; 
&lt;i&gt;P&lt;/i&gt;&amp;#160;&amp;lt;&amp;#160;.001), considerable overlap was seen in
RSMRs between non-PCI and PCI hospitals within the same HRR. In 80
HRRs, the RSMRs at the best-performing PCI hospital were lower than
those at local non-PCI hospitals by 3% or more. Among the remaining
HRRs, the RSMRs at the best-performing PCI hospital were lower by
1.5% to 3.0% in 104 HRRs and by greater than 0 to 1.5% in 74 HRRs.
In 37 HRRs, the RSMRs at the best-performing PCI hospital were no
better or were higher than at local non-PCI hospitals.&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;Conclusions&amp;#160;&lt;/b&gt; The magnitude of benefit from
comprehensively regionalizing AMI care to PCI hospitals appears to
vary greatly across HRRs. These findings support a tailored
regionalization policy that targets areas with the greatest outcome
differences between PCI and local non-PCI hospitals.&lt;/p&gt;&lt;/p&gt;</content>
  </entry>
  <entry>
    <title type="html">Hospice Study Finds Racial Disparities (CME/CE)</title>
    <id>tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fwww.medworm.com%2Frss%2Fmedicalfeeds%2Fspecialities%2FConsumer-Health-News.xml%3A3343008</id>
    <link href="http://www.mydailyapple.com/follow?doc=s3%3Ahttp%253A%2F%2Fwww.medworm.com%2Frss%2Fmedicalfeeds%2Fspecialities%2FConsumer-Health-News.xml%3A3343008" rel="alternate"/>
    <updated>2010-03-09T00:24:47Z</updated>
    <author>
      <name>http://www.medworm.com/rss/medicalfeeds/specialities/Consumer-Health-News.xml</name>
    </author>
    <summary type="html">&lt;p&gt;Among patients with advanced heart failure, blacks and Hispanics are less likely to receive hospice care than whites, researchers found. (Source: MedPage Today State Required CME)&lt;/p&gt;</summary>
    <content type="html">&lt;p&gt;Among patients with advanced heart failure, blacks and Hispanics are less likely to receive hospice care than whites, researchers found. (Source: MedPage Today State Required CME)&lt;/p&gt;</content>
  </entry>
  <entry>
    <title type="html">Racial and Ethnic Differences in Hospice Use Among Patients With Heart Failure [Original Investigation]</title>
    <id>tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Farchinte.ama-assn.org%3Ahttp%3A%2F%2Farchinte.ama-assn.org%2Fcgi%2Fcontent%2Fshort%2F170%2F5%2F427%3Frss%3D1</id>
    <link href="http://www.mydailyapple.com/follow?doc=s3%3Ahttp%253A%2F%2Farchinte.ama-assn.org%3Ahttp%3A%2F%2Farchinte.ama-assn.org%2Fcgi%2Fcontent%2Fshort%2F170%2F5%2F427%3Frss%3D1" rel="alternate"/>
    <updated>2010-03-09T00:24:47Z</updated>
    <author>
      <name>http://archinte.ama-assn.org</name>
    </author>
    <summary type="html">&lt;p&gt;&lt;p&gt;
&lt;b&gt;Background&amp;#160;&lt;/b&gt; Heart failure is the leading noncancer
diagnosis for patients in hospice care and the leading cause of
hospitalization among Medicare beneficiaries. Racial and ethnic
differences in hospice patients are well documented for patients
with cancer but poorly described for those with heart failure.&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;Methods&amp;#160;&lt;/b&gt; On the basis of a national sample of
98&amp;#160;258 Medicare beneficiaries 66 years and older on January 1,
2001, with a diagnosis of heart failure who had at least 1
physician or hospital encounter and who were not enrolled in
hospice care between January 1 and December 31, 2000, we determined
the effect of race and ethnicity on hospice entry for patients with
heart failure in 2001 after adjusting for sociodemographic,
clinical, and geographic factors.&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;Results&amp;#160;&lt;/b&gt; In unadjusted analysis, blacks (odds ratio
[OR],&amp;#160;0.52) and Hispanics (0.43) used hospice care for heart
failure less than whites. Racial and ethnic differences in patients
who received hospice care for heart failure persisted after
adjusting for markers of income, urbanicity, severity of illness,
local density of hospice use, and medical comorbidity (adjusted OR
for blacks, 0.59; 95% confidence interval, 0.47-0.73; and adjusted
OR for Hispanics, 0.49; 95% confidence interval, 0.37-0.66;
compared with whites). Advanced age, greater comorbidity, emergency
department visits, hospitalizations, and greater local density of
hospice use were also associated with hospice use.&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;Conclusions&amp;#160;&lt;/b&gt; In a national sample of Medicare
beneficiaries with heart failure, blacks and Hispanics used hospice
care for heart failure less than whites after adjustment for
individual and market factors. To understand the mechanisms
underlying these findings, further examination of patient
preferences and physician referral behavior is needed.&lt;/p&gt;&lt;/p&gt;</summary>
    <content type="html">&lt;p&gt;&lt;p&gt;
&lt;b&gt;Background&amp;#160;&lt;/b&gt; Heart failure is the leading noncancer
diagnosis for patients in hospice care and the leading cause of
hospitalization among Medicare beneficiaries. Racial and ethnic
differences in hospice patients are well documented for patients
with cancer but poorly described for those with heart failure.&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;Methods&amp;#160;&lt;/b&gt; On the basis of a national sample of
98&amp;#160;258 Medicare beneficiaries 66 years and older on January 1,
2001, with a diagnosis of heart failure who had at least 1
physician or hospital encounter and who were not enrolled in
hospice care between January 1 and December 31, 2000, we determined
the effect of race and ethnicity on hospice entry for patients with
heart failure in 2001 after adjusting for sociodemographic,
clinical, and geographic factors.&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;Results&amp;#160;&lt;/b&gt; In unadjusted analysis, blacks (odds ratio
[OR],&amp;#160;0.52) and Hispanics (0.43) used hospice care for heart
failure less than whites. Racial and ethnic differences in patients
who received hospice care for heart failure persisted after
adjusting for markers of income, urbanicity, severity of illness,
local density of hospice use, and medical comorbidity (adjusted OR
for blacks, 0.59; 95% confidence interval, 0.47-0.73; and adjusted
OR for Hispanics, 0.49; 95% confidence interval, 0.37-0.66;
compared with whites). Advanced age, greater comorbidity, emergency
department visits, hospitalizations, and greater local density of
hospice use were also associated with hospice use.&lt;/p&gt;
&lt;p&gt;
&lt;b&gt;Conclusions&amp;#160;&lt;/b&gt; In a national sample of Medicare
beneficiaries with heart failure, blacks and Hispanics used hospice
care for heart failure less than whites after adjustment for
individual and market factors. To understand the mechanisms
underlying these findings, further examination of patient
preferences and physician referral behavior is needed.&lt;/p&gt;&lt;/p&gt;</content>
  </entry>
  <entry>
    <title type="html">Your Health: Many women avoid calling 911</title>
    <id>tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fwww.medworm.com%2Frss%2Fmedicalfeeds%2Fspecialities%2FConsumer-Health-News.xml%3A3339951</id>
    <link href="http://www.mydailyapple.com/follow?doc=s3%3Ahttp%253A%2F%2Fwww.medworm.com%2Frss%2Fmedicalfeeds%2Fspecialities%2FConsumer-Health-News.xml%3A3339951" rel="alternate"/>
    <updated>2010-03-08T00:24:20Z</updated>
    <author>
      <name>http://www.medworm.com/rss/medicalfeeds/specialities/Consumer-Health-News.xml</name>
    </author>
    <summary type="html">&lt;p&gt;If you think you are having a heart attack or stroke, what would you do? Anything other than an immediate call for help can carry ... (Source: USATODAY.com Health)&lt;/p&gt;</summary>
    <content type="html">&lt;p&gt;If you think you are having a heart attack or stroke, what would you do? Anything other than an immediate call for help can carry ... (Source: USATODAY.com Health)&lt;/p&gt;</content>
  </entry>
  <entry>
    <title type="html">When It Comes To Health Records "IT" Can Mean Impaired Technology</title>
    <id>tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fwww.medicalnewstoday.com%2Frss%2Fit-internet-e-mail.xml%3Ahttp%3A%2F%2Fmnt.to%2Ff%2F3yzz</id>
    <link href="http://www.mydailyapple.com/follow?doc=s3%3Ahttp%253A%2F%2Fwww.medicalnewstoday.com%2Frss%2Fit-internet-e-mail.xml%3Ahttp%3A%2F%2Fmnt.to%2Ff%2F3yzz" rel="alternate"/>
    <updated>2010-03-08T00:24:20Z</updated>
    <author>
      <name>http://www.medicalnewstoday.com/rss/it-internet-e-mail.xml</name>
    </author>
    <summary type="html">&lt;p&gt;With the new health care IT technology already in use, preparation for the accompanying consequences should be on every family's mind, advises Martine Ehrenclou, author of the multiple award-winning, self-help guide Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive (Lemon Grove Press)...&lt;/p&gt;</summary>
    <content type="html">&lt;p&gt;With the new health care IT technology already in use, preparation for the accompanying consequences should be on every family's mind, advises Martine Ehrenclou, author of the multiple award-winning, self-help guide Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive (Lemon Grove Press)...&lt;/p&gt;</content>
  </entry>
  <entry>
    <title type="html">Predictive Biosciences To Present Novel Combination Approach To Molecular Cancer Diagnostics At 2010 Genitourinary Cancers Symposium</title>
    <id>tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fwww.medicalnewstoday.com%2Frss%2Fcancer-oncology.xml%3Ahttp%3A%2F%2Fmnt.to%2Ff%2F3yzw</id>
    <link href="http://www.mydailyapple.com/follow?doc=s3%3Ahttp%253A%2F%2Fwww.medicalnewstoday.com%2Frss%2Fcancer-oncology.xml%3Ahttp%3A%2F%2Fmnt.to%2Ff%2F3yzw" rel="alternate"/>
    <updated>2010-03-08T00:24:20Z</updated>
    <author>
      <name>http://www.medicalnewstoday.com/rss/cancer-oncology.xml</name>
    </author>
    <summary type="html">&lt;p&gt;Predictive Biosciences announced that the Company will be presenting its novel Multi-Analyte Diagnostic Readout (MADR&#8482;) approach to the development of a non-invasive, urinary biomarker based assay for the detection of bladder cancer during the 2010 Genitourinary Cancers Symposium (GU Symposium), being held March 5-7 in San Francisco...&lt;/p&gt;</summary>
    <content type="html">&lt;p&gt;Predictive Biosciences announced that the Company will be presenting its novel Multi-Analyte Diagnostic Readout (MADR&#8482;) approach to the development of a non-invasive, urinary biomarker based assay for the detection of bladder cancer during the 2010 Genitourinary Cancers Symposium (GU Symposium), being held March 5-7 in San Francisco...&lt;/p&gt;</content>
  </entry>
  <entry>
    <title type="html">Most early-stage breast cancer patients may not need radiation after mastectomy</title>
    <id>tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fwww.sciencedaily.com%2Frss%2Fhealth_medicine.xml%3A%2Freleases%2F2010%2F03%2F100306223837.htm</id>
    <link href="http://www.mydailyapple.com/follow?doc=s3%3Ahttp%253A%2F%2Fwww.sciencedaily.com%2Frss%2Fhealth_medicine.xml%3A%2Freleases%2F2010%2F03%2F100306223837.htm" rel="alternate"/>
    <updated>2010-03-08T00:24:20Z</updated>
    <author>
      <name>http://www.sciencedaily.com/rss/health_medicine.xml</name>
    </author>
    <summary type="html">&lt;p&gt;Breast cancer patients with early stage disease that has spread to only one lymph node may not benefit from radiation after mastectomy, because of the low present-day risk of recurrence following modern surgery and systemic therapy, a finding that could one day change the course of treatment for thousands of women diagnosed each year, according to researchers.&lt;/p&gt;</summary>
    <content type="html">&lt;p&gt;Breast cancer patients with early stage disease that has spread to only one lymph node may not benefit from radiation after mastectomy, because of the low present-day risk of recurrence following modern surgery and systemic therapy, a finding that could one day change the course of treatment for thousands of women diagnosed each year, according to researchers.&lt;/p&gt;</content>
  </entry>
</feed>
